Cancer remains a leading cause of death globally. In 2022 alone, more than 19 million people worldwide were diagnosed with cancer, and almost 10 million died of the disease. With more than a three-decade legacy in oncology innovation, our commitment to pioneer new therapeutic advances for patients with cancer has never been stronger.

We bring together global resources, expertise, research capabilities and alliances to develop new treatments for hematologic malignancies, including multiple myeloma, b-cell and myeloid malignancies, and solid tumors such as lung cancer, bladder cancer and prostate cancer.

From the discovery, development and delivery of transformational therapies, to collaborating with the brightest minds, we never settle in advancing the next wave of innovations and in driving towards cures. Our aim is not only to take down disease, but to change and save lives. Our aim is to be in front of cancer.


Learn more: Driving toward the elimination of cancer (PDF)